TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Tarsus Pharmaceuticals, Inc.
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Tarsus Pharmaceuticals will host a live webcast on November 4, 2025, to report its third quarter 2025 financial results and provide a corporate update. The company has FDA-approved XDEMVY for Demodex blepharitis and is developing additional treatments for eye care and infectious disease prevention.

Insights
CYCU   neutral

Mentioned as a partnership partner for AI-enhanced cybersecurity joint program


TARS   positive

Company is reporting record quarterly net product sales, expanding its product pipeline, and hosting an investor update, indicating growth and strategic development